Essential role of vascular endothelial growth factor in angiotensin II - Induced vascular inflammation and remodeling

被引:150
作者
Zhao, QW [1 ]
Ishibashi, M [1 ]
Hiasa, K [1 ]
Tan, CY [1 ]
Takeshita, A [1 ]
Egashira, K [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan
关键词
growth substances; arteriosclerosis; remodeling; angiotensin II; endothelial growth factors;
D O I
10.1161/01.HYP.0000138688.78906.6b
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II (Ang II) upregulates vascular endothelial growth factor ( VEGF) and activates vascular inflammation. However, the decisive role of VEGF in Ang II-induced vascular inflammation and remodeling has not been addressed. Ang II infusion to wild-type mice increased local expression of VEGF and its receptors in cells of aortic wall and plasma VEGF, and caused aortic inflammation ( monocyte infiltration) and remodeling ( wall thickening and fibrosis). Hypoxia-inducible factor-1alpha colocalized with VEGF-positive cell types. Blockade of VEGF by the soluble VEGF receptor 1 (sFlt-1) gene transfer attenuated the Ang II-induced inflammation and remodeling. The sFlt-1 gene transfer also inhibited the increased expression of VEGF and inflammatory factors such as monocyte chemoattractant protein-1. In contrast, sFlt-1 gene transfer did not affect Ang II-induced arterial hypertension and cardiac hypertrophy. VEGF is an essential mediator in Ang II-induced vascular inflammation and structural changes through its proinflammatory actions.
引用
收藏
页码:264 / 270
页数:7
相关论文
共 39 条
[1]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[2]   Somatic gene therapy in the cardiovascular system [J].
Baumgartner, I ;
Isner, JM .
ANNUAL REVIEW OF PHYSIOLOGY, 2001, 63 :427-450
[3]   CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension [J].
Bush, E ;
Maeda, N ;
Kuziel, WA ;
Dawson, TC ;
Wilcox, JN ;
DeLeon, H ;
Taylor, WR .
HYPERTENSION, 2000, 36 (03) :360-363
[4]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[5]   Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[6]   Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis [J].
Dzau, VJ .
HYPERTENSION, 2001, 37 (04) :1047-1052
[7]   Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth [J].
Egami, K ;
Murohara, T ;
Shimada, T ;
Sasaki, K ;
Shintani, S ;
Sugaya, T ;
Ishii, M ;
Akagi, T ;
Ikeda, H ;
Matsuishi, T ;
Imaizumi, T .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (01) :67-75
[8]   Molecular mechanisms mediating inflammation in vascular disease - Special reference to monocyte chemoattractant protein-1 [J].
Egashira, K .
HYPERTENSION, 2003, 41 (03) :834-841
[9]   Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys [J].
Egashira, K ;
Zhao, QW ;
Kataoka, C ;
Ohtani, K ;
Usui, M ;
Charo, IF ;
Nishida, K ;
Inoue, S ;
Katoh, M ;
Ichiki, T ;
Takeshita, A .
CIRCULATION RESEARCH, 2002, 90 (11) :1167-1172
[10]   Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease [J].
Egashira, K .
CIRCULATION JOURNAL, 2002, 66 (06) :529-533